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Abstract 
Here a novel electrochemical method for the rapid detection of anti-HIV antibodies 
in serum is presented. The novelty lies in the combination of allosteric enzymes and 
coulometry to yield a fast, simple and reliable HIV diagnostic method. We have 
used a previously developed β-galactosidase enzyme that is efficiently activated by 
anti-HIV antibodies directed against a major B-cell epitope of the gp41 
glycoprotein. When these antibodies bind the enzyme, the 3D conformation 
changes positively affecting the performance of the active site and, 
consequently, the enzyme activity is stimulated. Using 4-aminophenyl β-D-
galactopyranoside (PAPG) as substrate yields p-aminophenol (PAP), which is 
reversibly oxidised at a very mild potential, ca. 0.37 V vs. Ag/AgCl over a range of 
electrode materials within the working pH range of β-galactosidase. In the present 
case, photolithographically produced microelectrode arrays resulted in a detection 
limit of 4 µM for 4-aminophenol (PAP). The presence of anti-HIV antibodies results 
in enzyme activity increases above 50% which, combined with the sensitivity and 
response time afforded by the microelectrode arrays, allowed for the diagnosis of 
HIV in sera samples within an hour. 
 
 
Keywords: Disk microelectrode arrays; beta-galactosidase; amperometry of 4-
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1 Introduction 
The timely diagnostic of infectious diseases is key in clinical and veterinary 
medicine. Over the past 20 years, the human immunodeficiency virus (HIV) has 
been among the most studied emerging viruses and a high number direct and 
indirect of methods have been developed to detect its infection [5]. With direct 
methods, viral components (e.g. nucleic acids, proteins) are detected by antigen-
ELISA, [6] immunoperoxidase/peroxidase-immunoperoxidase staining, [7, 8] 
complement-fixation test, [9] immunofluorescence or Polymerase chain reaction 
(PCR) based methods [10-14], with Antibody-ELISA and agar-gel immunodiffusion 
being the most common [2]. Regardless of this, Significant efforts are being 
invested in the discovery of new strategies to detect infections with better 
sensitivity, reliability and test performance [2-4], and new methods are 
continuously being developed to either improve existing assays or to make new 
detection procedures available [1]. Portable and rapid detection platforms are 
particularly necessary in geographical regions lacking adequate medical facilities, 
and in these regions biosensing devices offer a promising alternative to 
conventional analytical methods [15, 16]. 
Allosteric enzymes can be used as efficient biocomponents as their activity is 
modulated by the specific recognition of target peptides, in general distant from the 
active site, by specific anti-peptide antibodies [17]. The construction of allosteric 
enzymes involves the identification of an antigenic peptide from the pathogen and 
its insertion using protein-engineering methods onto appropriate permissive sites in 
an enzyme. This offers intriguing possibilities in the fast and ultra-fast molecular 
diagnosis of infectious diseases because the allosteric reaction can be monitored in 
enzymatic assays and after short reaction times in simple homogeneous assays.  
Among the different enzymes suitable to be used as allosteric sensors [17], 
Escherichia coli β-galactosidase (β-D-galactoside hydrolase, E.C. 3.2.1.23) was 
chosen as a suitable enzyme to be used as an allosteric sensor as it hydrolyzes 
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lactose and synthetic analogues such as 4-aminophenyl β-D-galactopyranoside 
(PAPG), a substrate yielding p-aminophenol (PAP), a well-known electroactive 
product [18-20]. We are using this enzyme-substrate system in combination with 
microdisk electrode arrays [21] to develop a rapid and sensitive method to detect 
anti-HIV antibodies. To summarize, a small amount of modified β-galactosidase 
HisNF795gpC was incubated in parallel in a serum test sample and a blank. 
Following these incubations, PAPG was added and the allosteric activations in the 
samples were compared to each other via the direct oxidation of PAP at a microdisk 
electrode array. HIV positive human sera generated PAP at a significantly higher 
rate, demonstrating the feasibility of this electrochemical assay in real samples. 
2 Experimental 
2.1 Chemical reagents and instrumentation 
All chemicals used were analytical grade and were used as received from Sigma-
Aldrich without any further purification. These were: potassium chloride, potassium 
hexacyanoferrate (II), 4-aminophenol (PESTANAL grade, 99.9% purity), 
β-galactosidase, 4-Aminophenyl β-D-galactopyranoside, Bovine serum albumin 
(BSA) and magnesium sulphate heptahydrate. For the antibody detection 
experiments, a specially engineered β-galactosidase was used [22]. Buffer Z was 
prepared using commercial PBS tablets (Invitrogen) reaching a 0.1 M concentration 
and completed to 1 mM MgSO4 and 20 mM KCl. Solutions were prepared using 
deionised water of resistivity not less than 18 MΩ cm-1. All the material used was 
cleaned with bleach between experiments. The pH of the solutions was controlled 
using a METROHM 827 pH Lab meter with temperature correction.  
Human sera samples were generously provided by Dr. Miguel Angel Martínez 
(Fundació IRSI Caixa) and treated anonymously during all the procedures to make 
them untraceable. Seroconversion in HIV-infected individuals had been previously 
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determined by conventional routine immunoassays. Patients’ consent was given 
and approval of local ethical committee was obtained. 
Autolab PG12 potentiostat controlled by GPES 4 software running on a Windows XP 
based PC. A BAS (West Lafayette, IN, USA) 1.6 mm diameter gold electrode was 
used for the preliminary voltammetric study of 4-aminophenol. The analytical work 
was then performed with a series of disk microelectrode arrays as described below. 
A 5 cm long, 3 mm diameter glassy carbon rod was used as auxiliary electrode and 
an Ag/AgCl (3M KCl) Metrohm biotrode® was used as reference electrode. The 
temperature of all solutions was controlled by means of a jacketed cell connected to 
a thermostatic bath. 
2.2 Cloning, expression, purification and activity assay of 
HisNF795gpC 
The construction of his-tagged recombinant β-galactosidase HisNF795gpC, 
displaying HIV B-cell epitope from the gp41 envelope glycoprotein, was achieved 
adding a removable His6 tag and a Tobacco Etch Virus protease cleavage site at the 
N-terminal end of NF795gpC [22] by polymerase chain reaction. The specific DNA 
band obtained from pNF795gpC was subcloned into the NcoI and EcoRI unique 
restriction sites of pJLA602 [23] resulting in pHisNF795gpC which encodes 
engineered β-galactosidase under the control of the cI857-repressed lambda pL and 
pR strong promoters.  
Protein HisNF795gpC was produced in E. coli MC4100 by standard procedures [22]. 
Cells were spun down and re-suspended in buffer Z supplemented with 500 mM 
NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol and protease inhibitor cocktail 
tablets (Complete EDTA-free from Roche Applied Science). After sonication, the 
clarified supernatant was loaded on a nickel column (1 ml HiTrap chelating HP 
column, GE Healthcare) equilibrated with the same buffer. The column was washed 
with the loading buffer and the protein was eluted with a 10-300 mM imidazole 
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gradient. Positive protein fractions were detected by a miniaturised β-galactosidase 
activity assay in ELISA microtiter plates using ortho-nitrophenyl β-D-
galactopyranoside (ONPG) as substrate. Pooled positive protein fractions were 
dialysed against buffer Z. Protein concentration was obtained by spectrophotometry 
measurements at 260 and 280 nm and the enzymatic activity was determined by 
published variations of the Miller’s method [22]. 
2.3 Electrode Fabrication and Characterisation 
The thin film microelectrode arrays used in this study have been thoroughly 
described elsewhere [24, 25]. These arrays are made up of 128 microdisks, 10 
micron in diameter, arranged in a cubic lattice with an inter-centre separation of 
100 microns. The electrodes were first cleaned with ethanol and then 
electrochemically activated in 0.1 M KCl applying a series of potential pulses from 0 
V to -2 V vs. Ag/AgCl (3M KCl). The electrodes were then characterized by cyclic 
voltammetry in 1mM ferrocyanide solutions. Analysis of the limiting currents using 
the approach described in [26] at a range of scan rates enabled the elucidation of 
the number of active microdisks in the array throughout the experiments. This 
operation was repeated after each measurement to determine the degree of 
microelectrode passivation. Although electrode performance was generally affected 
by the adsorption of proteins present in the samples, it was possible to recover the 
full response of the arrays following a new cycle of electrochemical activation in an 
electrolyte solution. 
3 Results and Discussion 
Electrochemistry of 4-aminophenol 
The detection of anti-HIV antibodies is indirectly reported by the oxidation of 4-
aminophenol, PAP, which is produced by β-galactosidase from 4-Aminophenyl-β-D-
galactopyranoside, PAPG. [27, 28] The electrochemistry of PAP is well known and 
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numerous literature reports deal with the subject. [20, 27, 29-32] The advantage 
of using a PAP related substrate lays in that PAP is reversibly oxidised at a mildly 
positive potential (Eo’ ca. 0.3 V vs. Ag/AgCl (3M KCl)), causing next to no electrode 
fouling (unlike o-aminophenol, p-aminophenol is reported not polymerise upon 
oxidation at an electrode [33]). Unfortunately, the oxidation product is unstable 
and is known to undergo hydrolysis over a wide range of pHs but specially under 
very acidic conditions [34]. This makes the oxidation of PAP a classical example of 
the EC mechanism. [29].  
     Eq. 1 
k1 is a first order constant around 0.020 s-1 [29] at pH=1.18. According to this, the 
follow-up C step should not be an issue in our case since all our solutions were 
buffered at a pH=7.5, where the hydrolysis step is believed to be slower. On the 
other hand, we found 4-aminophenol to adsorb weakly on our gold working 
electrodes. Having said this, adsorption was not found to be detrimental to the 
overall performance of the enzymatic assay, and any remains on the electrodes 
could be easily removed by rinsing with DMF. Figure 1 shows a sample cyclic 
voltammogram of 0.5 mM PAP at pH=7.5 at 50 mVs-1 over a 128 microdisk 
microelectrode array. An apparent diffusion coefficient of (7.44±0.91) x 10-10 m2 s-1 
was estimated by analysis of the oxidation peak currents at a macroelectrode. This 
is in good agreement with an estimated value of 8.60x10-10 m2 s-1, obtained by 
application of the Wilke-Chang semiempirical approximation [35]. 
Although electrochemical reversibility is an interesting feature in itself for 
amperometric biosensors, what makes it even more attractive is the fact that its 
parent enzyme substrate, PAPG, is not electroactive at the detection potential for 
aminophenol. From the voltammetry, we decided to subsequently use 0.37 V vs. 
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Ag/AgCl (3M KCl) as working potential for the amperometric detection of PAP under 
diffusion control. The detection limit for 4-aminophenol was determined from the 
limiting currents measured at 100 mV s-1 at four calibrated 128 disk microelectrode 
arrays. This scan rate ensured diffusional independence between micro disks [36, 
37], and a sample calibration plot is provided in Figure 2. We found this limit for 
PAP to be 4 µM using the propagation of errors approach [38] as it is more realistic 
than the 1.8 µM obtained from application of IUPAC’s 3σ method [39]. 
Electrochemical detection of wild type β -galactosidase 
activity 
The 4-aminophenol formed by activity of β-galactosidase is readily oxidised at the 
electrode surface. This was ensured from a series of control experiments. These 
consisted in separate electrochemical studies of the starting materials alone. Figure 
3.a shows that neither the substrate nor β-galactosidase alone brought about any 
significant currents at the working potential over a span of 20 minutes. However, 
when the two were mixed together, 4-aminophenol was immediately generated. 
The increase of this product was linear during the early stages of the process, which 
enabled the study of the enzyme kinetics. The dependency upon substrate 
concentration was performed at a β–galactosidase concentration of 2 µg ml-1 and 
different substrate amounts (0.05, 0.10, 0.25 and 0.50 mg ml-1). We measured the 
output current for 30 minutes, which enabled us to monitor the rate of product 
formation. Enzyme activity, measured from the initial slope, was proportional to the 
concentration of substrate introduced in the system. Figure 3.b depicts the 
response obtained over time and the slopes calculated for the different initial 
substrate concentration. Using these results the parameters governing the system 
kinetics were elucidated assuming a Michaelis-Menten type mechanism [40]. Data 
analysis yielded Km and kcat values of 4.3±0.1 x10-4 mol l-1 and 0.08±0.05 s-1, 
respectively. 
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His-NF795gpC: detection of anti- HIV antibodies in sera 
We used mutant versions of the Escherichia coli β-galactosidase that are 
enzymatically responsive to antibodies against human immunodeficiency virus 1 
(HIV-1) [22]. These custom-made enzymes, when used as biosensing tools, 
showed specificities and sensitivities comparable to conventional antibody detection 
immunoassays [22]. Solving the structural rationale for the sensing mechanics [41-
46] has permitted to optimize the performance of the engineered proteins by 
dramatically shortening the reaction time [47] and reaching signal:background 
ratios higher than 10 [48, 49]. The improved versions of the allosteric sensing 
reactions permit the use of these molecular sensors in high-throughput sera 
analysis [50]. 
Given that His-NF795gpC is more unstable than the wild type enzyme, 
measurements were conducted in buffer Z containing 1% (w/v) BSA. However, 
electrochemical monitoring of enzyme activity was still feasible at the 
microelectrode array. Figure 4 shows that the current decayed after going through 
a maximum at higher enzyme activities. This was thought to be due to the 
depletion of the diffusion layer at the microelectrode array after the quantitative 
consumption of the enzyme substrate at higher enzyme levels. The initial 
concentration of substrate was close to 1 mM, which might have eventually led to 
the production of 1 mM aminophenol. The magnitude of the peak current, near 300 
nA, would correspond to an aminophenol concentration in that range, considering 
Figures 1 and 2. Other factors affecting the current response were microelectrode 
passivation, caused by adsorption of protein, and perhaps enzyme inhibition. 
Although we cannot rule out enzyme inhibition, we believe it was negligible under 
our experimental conditions and that the current decay can simply be explained by 
a combination of substrate consumption and electrode passivation. 
The oxidation current arising from PAP formation was recorded following addition of 
the substrate into the electrochemical cell. Incubation of His-NF795gpC with 
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positive sera enhanced its activity by over 56% in all cases studied. In the assays 
carried out in real samples, 2 µg L-1 of enzyme were incubated for 45 minutes with 
a 1/60 final dilution of a sera pool from HIV-1 infected individuals. 
Figure 5 shows the results of the main experiment, consisting on incubating the 
enzyme with a bank of serial dilutions from two distinct sera coming from HIV-
infected and HIV-negative individuals, respectively, in the presence of 
HisNF795gpC. For each condition, three measurements were conducted to obtain 
the mean and the corresponding error bars. We used combined standard deviations 
at 95% confidence as the measure of error† [51]. Antibody recognition resulted 
optimum for a serum dilution of 1/320. The activity increase was not enhanced any 
further beyond this point of serum concentration. Coulometry was found to be more 
reliable than measuring the initial velocity of the enzymatic reaction or current 
intensity after 20 minutes of measurement, showing better accuracy and being able 
to operate under lower enzyme and substrate concentrations. The current decays 
observed in the presence of higher protein concentrations are likely due to 
electrode fouling rather than enzyme inhibition. The activity enhancement in the 
positive serum samples is also clear. Table 1 gives the values of the initial velocities 
                                           
† Since all standard deviations are due to the testing method, it is possible to combine them to obtain a 
parameter that quantifies the variability of the latter. Combining standard deviations does not mean to 
average standard deviations, since that would not account for the fact that different samples may 
contain a different level of antibodies in them. The way to calculate the combined standard deviation is: 
 
CSD = ! df( ) s2( )"# $% ! df( ) , where df represents the degrees of freedom, and s is the standard 
deviation of each data set. The combined standard deviation is a better estimation of the population 
standard deviation because it has more degrees of freedom. Thus, when calculating confidence intervals, 
the value of Student’s t parameter can be significantly decreased. The result of this approach is that 
lower detection limits can be reached, and is of great help in samples at the lower concentration range 
where very small slope or current plateau changes are produced. Reproducibility could be achieved 
because re-activation and characterisation of the arrays was conducted between measurements. 
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of PAP production before and after incubation with the serum. Although a bigger 
activity change was observed for the low enzyme concentration (72% vs. 56%), we 
chose to work with 2µg ml-1 enzyme concentration in subsequent experiments 
because the resulting currents were easier to measure.  
Three parameters were compared: (i) the initial velocity of the enzymatic reaction, 
determined during the first five minutes of operation, (ii) signal intensity reached 
after 20 minutes of measurement and (iii) total charge passed throughout the 
experiment. The three graphs are depicted in figure 5a-c. As the figure shows, for 2 
µg ml-1 HisNF795gpC, the antibody recognition was optimum for a serum dilution of 
1/320. In fact the activity increase was not enhanced any further beyond this point 
of serum concentration. Current losses were observed both in the infected sample 
and in the blank above this optimum serum concentration. This effect has been 
explained above as a combination of substrate depletion and electrode fouling, and 
it does not prevent the feasibility of the measurement. Among the three 
approaches to determine the presence of anti-HIV antibodies, the coulometric 
(figure 5c) seems the most reliable, followed by the amperometric mode and finally 
the initial slope. Although the initial slope method may be the quickest, it is also 
less sensitive than the others. The amperometric method is more sensitive, but it 
requires high enzyme and substrate concentrations. Besides, if the substrate were 
quantitatively consumed, as it happened in our case, the measurement might be 
subject to relatively large errors. Despite the fact that in our long 
chronoamperometric measurement we may have partially lost the current 
amplification feature of microelectrode arrays, the fact is that electrical noise pickup 
and capacitive currents were negligible compared to faradaic response. The 
coulometric method, on the other hand, showed better accuracy and it could 
operate under low enzyme and substrate concentrations. Given that charge 
accumulates over time, the fact that the currents are in the low nanoampere range 
may not necessarily prevent a successful measurement if the reaction is left to 
proceed for a few minutes. 
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4 Conclusions and Further Prospects 
We were able to measure the presence of anti-HIV antibodies in serum by 
measuring enzyme activity of an allosteric β-galactosidase over p-aminophenyl β-D-
galactopyranoside using disk microelectrode arrays to directly oxidise the p-
aminophenol produced in the reaction. The novelty of this research stems from the 
use of major technological advances in allosteric enzymes and microelectrode 
arrays, which enable the successful electrochemical detection of p-aminophenol in 
blood serum, indicating HIV infection. 
HIV infection is detected by measuring the difference in enzyme activity between a 
sample and a blank, with a positive sample producing a higher yield of the 
electroactive product p-aminophenol. 
Methodology improvements may be generated from a thorough optimisation of the 
chemical conditions such as pH, salinity, protein and substrate concentrations, and 
better microelectrode design may lead to a shorter analysis time.  
Also better-engineered microsystems could produce a more cost effective process 
by reducing the quantity of reagents required and, more importantly, thereby 
reducing the cost of disposal. Interestingly, the recent finding that allosteric sensing 
is maintained in immobilized enzyme versions [48] offers new possibilities to 
develop optimized platforms holding the sensing reaction, so that an integrated 
micro-electrochemical cell - able to handle sample volumes in the order of 
microlitres - may turn this method into a true competitor to current ELISA and 
Western blot assays. 
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Tables 
Table 1 
 
Condition tested 
Initial velocity (linear part 
slope) / A s-1 
Initial velocity increase 
after serum addition. 
Serum and substrate;  
no β-gal (control) 
0.00  
0.86 µg ml-1 β-gal ; 
 incubation without serum 
4.84x10-11 
0.86 µg ml-1 β-gal ; 
 incubation with serum 
         8.33x10-11 
72.1 % 
2µg ml-1 β-gal ; 
 incubation without serum. 
4.00x10-10  
2µg ml-1 β-gal ; 
 incubation with serum. 
6.25x10-10 
56.2 % 
 
 
Caption to tables 
Table 1: Increase of the engineered β-Gal activity after incubation with HIV-
antibody containing sera. 
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Caption to figures 
Figure 1: Cyclic voltammetry of 0.5 mM 4-aminophenol (PAP) in a phosphate 
buffered solution at a gold microelectrode array composed of 128 microdisks of 5 
mm radius and inter-central distance of 100 microns arranged in a square lattice. 
 
Figure 2: Typical calibration plot resulting from the measurement of the oxidation 
current of 4-aminophenol at a gold microelectrode array. The detection limit (see 
inset) is ca. 4 µM. 
 
Figure 3: (a) Chronoamperograms recorded at the microelectrode array at a 
constant potential 0.37 V. in solutions containing (Χ) the substrate alone at 0.25 
mg.ml-1, (▲) β-galactosidase alone at 2µg.ml-1 or (●) both the substrate (0.25 
mg.ml-1) and the enzyme (2 µg.ml-1) in buffer Z. (b) Evolution of the slopes 
obtained from the linear part of the curves corresponding to substrate additions to 
a solution containing 0.2 µg.ml-1 of β-galactosidase and fitting to the corresponding 
Michaelis-Menten-type rate law. 
 
Figure 4: Chronoamperograms measured at 0.37 V vs. Ag/AgCl (3M KCl) at two 
different HisNF795gpC concentrations after a 45-minute incubation at 28ºC in the 
presence or absence of a 1/60 final dilution serum containing anti-HIV antibodies. 
Substrate concentration was 0.25 mg.ml-1. 2µg.ml-1 HisNF795gpC concentration 
with (■) or without (□) contaminated serum and a 0.86 µg.ml-1 HisNF795gpC with 
(▲) or without (Δ) serum. A negative control with serum but no HisNF795gpC was 
also performed (●). 
 
Figure 5: Intensity obtained from (a) initial slope values, (b) final current and (c) 
total charge passed after 20 minutes applying 0.37 V. The signals correspond to the 
activity of HisNF795gpC in contact with 0.25 mg.ml-1 substrate following 45 
  15 
minutes incubation at 28ºC with anti-HIV antibodies positive serum (■) or negative 
serum (□). 
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